Stately Bio

iOrganBio

This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

Cellvoyant

Cellvoyant develops AI-powered imaging platforms and services to predict and optimise stem cell differentiation for biotechnology and pharmaceutical organisations developing cell-based therapies.

Cellino

The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

StemoniX

This deep-tech company develops human stem cell-derived organoid platforms for pharmaceutical and biotechnology customers to conduct drug discovery and toxicity screening.

Transforming cells into cures

This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.

Cellino Bio

This company develops an autonomous biomanufacturing platform that uses artificial intelligence and lasers to produce personalised cell therapies for patients with degenerative diseases.